Delia Lanzillotta

Magna Graecia University — Italy

Biochemistry, Genetics and Molecular Biology · Life Sciences

5h-index76citations12works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Ubiquitin and proteasome pathways(2), Genetics and Neurodevelopmental Disorders(2), Cholinesterase and Neurodegenerative Diseases(2), Protein Tyrosine Phosphatases(2), Enzyme function and inhibition(2)

Publications12 total

Corrigendum: Overcome Chemoresistance: Biophysical and Structural Analysis of Synthetic FHIT-Derived Peptides
Frontiers in Molecular Biosciences·2022Open Access
SASC: A simple approach to synthetic cohorts for generating longitudinal observational patient cohorts from COVID-19 clinical data
Patterns·2022· 6 citedOpen Access
Overcome Chemoresistance: Biophysical and Structural Analysis of Synthetic FHIT-Derived Peptides
Frontiers in Molecular Biosciences·2021· 1 citedOpen Access
<i>SASC</i>: A Simple Approach to Synthetic Cohorts for Generating Longitudinal Observational Patient Cohorts from COVID-19 Clinical Data
SSRN Electronic Journal·2021Open Access
Natural Products Extracted from Fungal Species as New Potential Anti-Cancer Drugs: A Structure-Based Drug Repurposing Approach Targeting HDAC7
Molecules·2020· 10 citedOpen Access
In Silico Identification and Biological Evaluation of Antioxidant Food Components Endowed with Human Carbonic Anhydrase IX and XII Inhibition
Antioxidants·2020· 11 citedOpen Access
In Silico Identification and Biological Evaluation of Antioxidant Food Components Endowed with IX and XII hCA Inhibition
Preprints.org·2020· 4 citedOpen Access
Multi-Targeting Bioactive Compounds Extracted from Essential Oils as Kinase Inhibitors
Molecules·2020· 17 citedOpen Access
Abstract B122: The CD98hc oncoprotein as a target of new anticancer therapy
Molecular Cancer Therapeutics·2019
Functional characterization of p.Pro409His variant in HNF1A, a hypomorphic mutation involved in pancreatic β-cell dysfunction
Acta Diabetologica·2019· 4 cited
Design, Synthesis, Biological Activity, and Structural Analysis of Lactam‐Constrained PTPRJ Agonist Peptides
ChemMedChem·2018· 3 cited
The receptor protein tyrosine phosphatase PTPRJ negatively modulates the CD98hc oncoprotein in lung cancer cells
Oncotarget·2018· 20 citedOpen Access

Frequent Co-authors

Francesco Trapasso(10), Giosuè Costa(5), Anna Artese(5), Stefano Alcaro(5), Annalisa Maruca(4), Roberta Rocca(4), Sabrina D’Agostino(3), Eugenio Gaudio(3), Francesco Mesiti(3), Alessandro Salatino(3), Marina Sala(3), Maria Carmina Scala(3), Anna Bilotta(2), Vincenzo Dattilo(2), Francesco Paduano(2), Rodolfo Iuliano(2), Nicola Perrotti(2), Raffaella Catalano(2), Francesco Ortuso(2), Francesca Alessandra Ambrosio(2)